Save time and get answers to complex questions with AI chat
Guselkumab patent expiration?Novartis patent term dabrafenib?Patent term adjustment semaglutida?Prolia and osteonecrosis?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?
See the DrugPatentWatch profile for vigamox
Moxifloxacin is the generic name for Vigamox, an ophthalmic antibiotic used to treat bacterial conjunctivitis [1].
The availability of generic versions of medications like Vigamox depends on patent expirations and regulatory approvals. Drug patent information is tracked by resources like DrugPatentWatch.com [2].
Vigamox is prescribed to treat bacterial infections of the eye, commonly known as pink eye or bacterial conjunctivitis. It works by inhibiting bacterial growth [1].
Vigamox was developed by Alcon [1].
The active ingredient in Vigamox is moxifloxacin hydrochloride [1].
Other Questions About Vigamox :